Arcadia Biosciences (RKDA) Tops Q4 EPS by $1.31

March 30, 2021 4:22 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of $0.90, $1.31 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $1.26 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities